BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 19176598)

  • 1. Human cardiac gap-junction coupling: effects of antiarrhythmic peptide AAP10.
    Hagen A; Dietze A; Dhein S
    Cardiovasc Res; 2009 Jul; 83(2):405-15. PubMed ID: 19176598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation.
    Weng S; Lauven M; Schaefer T; Polontchouk L; Grover R; Dhein S
    FASEB J; 2002 Jul; 16(9):1114-6. PubMed ID: 12039852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.
    Dhein S; Hagen A; Jozwiak J; Dietze A; Garbade J; Barten M; Kostelka M; Mohr FW
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):221-34. PubMed ID: 19943035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase Calpha mediates the effect of antiarrhythmic peptide on gap junction conductance.
    Dhein S; Weng S; Grover R; Tudyka T; Gottwald M; Schaefer T; Polontchouk L
    Cell Commun Adhes; 2001; 8(4-6):257-64. PubMed ID: 12064599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-arrhythmic peptide AAP10 remodels Cx43 and Cx40 expression and function.
    Easton JA; Petersen JS; Martin PE
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul; 380(1):11-24. PubMed ID: 19326099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desipramine prevents cardiac gap junction uncoupling.
    Jozwiak J; Dietze A; Grover R; Savtschenko A; Etz C; Mohr FW; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Nov; 385(11):1063-75. PubMed ID: 22965471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide specifically reduces the permeability of Cx37-containing gap junctions to small molecules.
    Kameritsch P; Khandoga N; Nagel W; Hundhausen C; Lidington D; Pohl U
    J Cell Physiol; 2005 Apr; 203(1):233-42. PubMed ID: 15481066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy.
    Eloff BC; Gilat E; Wan X; Rosenbaum DS
    Circulation; 2003 Dec; 108(25):3157-63. PubMed ID: 14656916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and regulation of connexins in cultured ventricular myocytes isolated from adult rat hearts.
    Polontchouk LO; Valiunas V; Haefliger JA; Eppenberger HM; Weingart R
    Pflugers Arch; 2002 Mar; 443(5-6):676-89. PubMed ID: 11889564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in gap junction conductance by an antiarrhythmic peptide.
    Müller A; Gottwald M; Tudyka T; Linke W; Klaus W; Dhein S
    Eur J Pharmacol; 1997 May; 327(1):65-72. PubMed ID: 9185837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of connexins 40 and 43 enhances the pH sensitivity of gap junctions: a model for synergistic interactions among connexins.
    Gu H; Ek-Vitorin JF; Taffet SM; Delmar M
    Circ Res; 2000 May; 86(10):E98-E103. PubMed ID: 10827142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17beta-estradiol reduces the effect of metabolic inhibition on gap junction intercellular communication in rat cardiomyocytes via the estrogen receptor.
    Chung TH; Wang SM; Wu JC
    J Mol Cell Cardiol; 2004 Nov; 37(5):1013-22. PubMed ID: 15522278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological enhancement of cardiac gap junction coupling prevents arrhythmias in canine LQT2 model.
    Quan XQ; Bai R; Lu JG; Patel C; Liu N; Ruan Y; Chen BD; Ruan L; Zhang CT
    Cell Commun Adhes; 2009; 16(1-3):29-38. PubMed ID: 19629804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction.
    Camelliti P; Devlin GP; Matthews KG; Kohl P; Green CR
    Cardiovasc Res; 2004 May; 62(2):415-25. PubMed ID: 15094361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression.
    Salameh A; Frenzel C; Boldt A; Rassler B; Glawe I; Schulte J; Mühlberg K; Zimmer HG; Pfeiffer D; Dhein S
    FASEB J; 2006 Feb; 20(2):365-7. PubMed ID: 16352648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal rat cardiomyocytes show characteristics of nonhomotypic gap junction channels.
    Schulte JS; Scheffler A; Rojas-Gomez D; Mohr FW; Dhein S
    Cell Commun Adhes; 2008 May; 15(1):13-25. PubMed ID: 18649175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of connexin 45 with connexin 43 decreases gap junction size.
    Grikscheit K; Thomas N; Bruce AF; Rothery S; Chan J; Severs NJ; Dupont E
    Cell Commun Adhes; 2008 May; 15(1):185-93. PubMed ID: 18649189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of combined amiodarone and antiarrhythmic peptide use on the cardiac gap junctions and incidence of induced ventricular arrhythmias in healed myocardial infarction rabbit models].
    Li LD; Zhang CT; Ruan L; Ni MK; Fang Y; Wang GQ; Wang XF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1102-7. PubMed ID: 21215147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of the antiarrhythmic peptide AAP10 on intercellular coupling.
    Müller A; Schaefer T; Linke W; Tudyka T; Gottwald M; Klaus W; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):76-82. PubMed ID: 9228193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarization pattern.
    Dhein S; Larsen BD; Petersen JS; Mohr FW
    Cell Commun Adhes; 2003; 10(4-6):371-8. PubMed ID: 14681044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.